Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma
qimono / Pixabay

Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma

According to a recent report in Cancer Network, the results from CARTITUDE-1 were well received. CARTITUDE-1 is a phase 1b/2 clinical trial of the CAR T-cell treatment, Cilta-Cel, for the…

Continue Reading Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma
Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
source: pixabay.com

Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity

  According to data from the STOMP trial involving thirty-four patients, a triple regimen has been proven to induce durable responses in pretreated patients with relapsed/refractory multiple myeloma. A recent…

Continue Reading Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
source: pixabay.com

Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know

According to a story from LocalHealthGuide, COVID-19 has continued to spread through the US and the lackluster government response suggests that it isn't going to be contained any time soon.…

Continue Reading Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
source: pixabay.com

Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment

According to a story from businesswire.com, the Bristol Myers Squibb Company recently released the topline results from its phase 3 clinical trial. This study was testing a combination treatment consisting…

Continue Reading Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients